Pharmaceutical products containing protein-tyrosine kinase inhibitors and anti-cd4 antibodies

摘要

There is disclosed a pharmaceutical product comprising a protein-tyrosine kinase p56 inhibitor and an anti-CD4 antibody for simultaneous combined, simultaneous separate or sequential use in therapy and use of such products in medicine for instance by promotion of differentiation of Th2 cells.